Risk of head and neck cancer among opium users

Copyright © 2023 Elsevier Ltd. All rights reserved..

OBJECTIVE: The scientific literature presents conflicting data on a possible causal relationship between opium users and the development of head and neck cancer (HNC). This study aimed to explore the risk of HNC among opium users is a narcotic addictive drug.

DESIGN: A systematic review and meta-analysis encompassed academic databases and gray literature up to May 2023, focusing on epidemiologic observational studies that reported the effect size of the HNC risk and opium use.

RESULTS: This study incorporated 14 effect size estimations to examine the association between opium use and the risk of head and neck cancers based on various HNC sub-sites, including the lip and oral cavity, pharynx, and larynx. The random effect model revealed a significant correlation between combined HNCs and opium use (odds ratio [OR]: 4.88; 95 % confidence interval [CI]: 2.99, 7.96). Additionally, opium consumption significantly increased the incidence of lip and oral cavity cancers (OR: 1.82; 95 % CI: 1.25, 2.65). Opium users faced an approximately eightfold increase in laryngeal cancer risk (OR: 7.86; 95 % CI: 4.66, 13.24) compared to non-opium users.

CONCLUSIONS: In summary, our findings strongly suggest that opium use is emerging as a significant risk factor for HNC. This underscores the need for further research and focused preventive measures to address this concerning association.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

2023

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:157

Enthalten in:

Archives of oral biology - 157(2023) vom: 17. Jan., Seite 105846

Sprache:

Englisch

Beteiligte Personen:

Mohebbi, Elham [VerfasserIn]
Alimoradi, Zainab [VerfasserIn]
Rozek, Laura S [VerfasserIn]
Mohebbi, Azadeh [VerfasserIn]
Jafari, Elahe [VerfasserIn]

Links:

Volltext

Themen:

8008-60-4
Head and Neck Neoplasms
Journal Article
Laryngeal Neoplasms
Meta-Analysis
Opium
Oral Cavity Squamous Cell Carcinoma
Review
Substance-related disorder
Systematic Review

Anmerkungen:

Date Completed 05.12.2023

Date Revised 05.12.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.archoralbio.2023.105846

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM364723688